Labcorp Holdings (LH) free cash flow

Free cash flow · fiscal 2025
$1.21B

Labcorp Holdings (LH) generated free cash flow of $1.21B in fiscal 2025 (the year ended December 31, 2025). That is 10.0% higher than the $1.10B of fiscal 2024. Figures as of 18 Nov 2026, 12:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.21B
Change on fiscal 2024
+10.0%
Growth, 5 years
−7.2% a year
Growth, 10 years
+5.2% a year
Highest on record
$2.69Bfiscal 2021
Lowest on record
$535.50Mfiscal 2014
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Labcorp Holdings free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 7.2% a year; over ten years the rate was 5.2% a year. Across the 19 fiscal years on record (2007–2025), the highest was $2.69B in fiscal 2021 and the lowest $535.50M in fiscal 2014.

History · 19 fiscal years

Free cash flow by fiscal year

Labcorp Holdings free cash flow, year by year

Labcorp Holdings (LH) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.21B 10.0% up
2024$1.10B 25.4% up
2023$874.10M 42.7% down
2022$1.53B 43.2% down
2021$2.69B 53.3% up
2020$1.75B 67.9% up
2019$1.04B 12.8% up
2018$925.60M 21.9% down
2017$1.19B 29.1% up
2016$918.20M 26.4% up
2015$726.60M 35.7% up
2014$535.50M 13.1% down
2013$616.50M 7.7% down
2012$667.60M 6.0% down
2011$709.90M 6.3% down
2010$757.50M 1.3% up
2009$747.70M 19.8% up
2008$624.20M 10.1% up
2007$567.10M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Labcorp Holdings and comparable companies
CompanyFree cash flowFiscal year
ResMed RMD$1.63B2026
Zoetis ZTS$2.28B2025
Labcorp Holdings LH$1.21B2025
DexCom DXCM$1.08B2025
Koninklijke Philips PHG€504.00M2025
Roivant Sciences ROIV-$758.56M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LH

Labcorp Holdings, figure by figure

Labcorp Holdings (LH) overview: price, valuation and scorecardAll health care companies by market value

Labcorp Holdings free cash flow: questions and answers

What is Labcorp Holdings's free cash flow?

Labcorp Holdings (LH) generated free cash flow of $1.21B in fiscal 2025 (the year ended December 31, 2025). That is 10.0% higher than the $1.10B of fiscal 2024.

What is the growth rate of Labcorp Holdings's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 7.2% a year; over ten years the rate was 5.2% a year.

What are the highest and lowest free cash flow figures on record for Labcorp Holdings?

Across the 19 fiscal years on record (2007–2025), the highest was $2.69B in fiscal 2021 and the lowest $535.50M in fiscal 2014.

How is Labcorp Holdings's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Labcorp Holdings it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Labcorp Holdings (LH) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/LH/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.